Where biomanufacturing reality meets commercial execution.
Sweetgrass Bio partners with advanced therapy and biologics organizations to connect commercial strategy with manufacturing, quality, and regulatory considerations. Our perspective comes from years of working alongside therapeutic developers and CDMOs to support program planning, manufacturing partnerships, and commercial execution across biologics and plasmid DNA.
“Valued for its resilience, adaptability, and subtle strength, native sweetgrass thrives in diverse and challenging environments. That deep rooted philosophy is the model for how we work at Sweetgrass Bio.” Christy Franco, PhD · Founder, Sweetgrass Bio
Your commercial partner with manufacturing depth and scientific fluency.
“The strongest commercial strategies are built with a clear understanding of how therapeutic programs evolve from early development through GMP manufacturing.”
Founded in 2025, Sweetgrass Bio is led by Dr. Christy Franco, a commercial leader with more than 15 years of experience working at the intersection of therapeutic developers and CDMOs. With a Ph.D. in Bioengineering from Rice University and deep expertise across the plasmid DNA value chain, she spent more than a decade supporting business development, alliance management, commercial operations, and program strategy for one of the world’s leading plasmid DNA CDMOs. Throughout that time, she worked closely with developers to align manufacturing approaches, program scope, commercial objectives, and long-term partnership strategies with the unique needs of each therapeutic program.
Those experiences shaped Sweetgrass Bio’s approach. Successful commercialization depends on manufacturing and partnership decisions made early in development, a lesson reinforced while supporting clients through periods of industry growth and supply disruption. Today, Sweetgrass Bio helps developers, CDMOs, and platform technology companies make better commercial and partnership decisions as programs mature.
Integrated expertise across three practice areas.
Sweetgrass Bio works alongside your team to build stronger commercial strategies, manufacturing partnerships, and business development systems that support long-term growth.
Whether you’re commercializing a new platform or expanding manufacturing partnerships, we help identify the right opportunities and build sustainable business development strategies.
- Fractional business development
- BD Pipeline design & qualification
- Partnering strategy & negotiations
- MKT positioning & competitive landscape
- Conference & campaign planning
As therapeutic programs mature, manufacturing decisions become increasingly strategic. We help align manufacturing partnerships, program planning, and commercial objectives for long-term success.
- Manufacturing partnership strategy
- Program scope alignment
- Commercial readiness planning
- Technology transfer planning
- Capabilities positioning
As organizations grow, commercial processes need to mature alongside them. We build the systems, playbooks, and infrastructure needed to support sustainable growth.
- Go-to-market strategy for new platforms
- Pricing & contracting frameworks
- Proposal & RFP response systems
- CRM structure & implementation
- Commercial team onboarding & training
Organizations we work alongside.
Connect in Person.
Sweetgrass Bio participates in key advanced therapies conferences throughout the year. Reach out ahead of an event to schedule a one-on-one meeting.
Exhibition and conference dedicated to accelerating breakthroughs across the advanced therapy industry.
Representing Richter BioLogics. Schedule a one-on-one meeting via the Partnering System or send an email to connect in person.
Annual partnering and networking event for advanced therapy executives.
Let's talk about what you're building.
Whether you're evaluating a manufacturing partnership, bringing a new platform to market, or strengthening the commercial systems needed to support growth, we'd be glad to connect and discuss.
